Cargando…
Deepening of response to prostate-specific membrane antigen ligand-targeted radioligand therapy beyond end of treatment
Autores principales: | Derlin, Thorsten, Krischke, Elke, Ross, Tobias L., Bengel, Frank M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426232/ https://www.ncbi.nlm.nih.gov/pubmed/33796886 http://dx.doi.org/10.1007/s00259-021-05335-x |
Ejemplares similares
-
Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy
por: Widjaja, Liam, et al.
Publicado: (2022) -
[(153)Sm]Samarium-labeled FAPI-46 radioligand therapy in a patient with lung metastases of a sarcoma
por: Kratochwil, Clemens, et al.
Publicado: (2021) -
PSMA Expression Predicts Early Biochemical Response in Patients with Metastatic Castration-Resistant Prostate Cancer under (177)Lu-PSMA-617 Radioligand Therapy
por: Widjaja, Liam, et al.
Publicado: (2021) -
Comparison of pretherapeutic osseous tumor volume and standard hematology for prediction of hematotoxicity after PSMA-targeted radioligand therapy
por: Widjaja, Liam, et al.
Publicado: (2021) -
In the thick of it: peroral endoscopic myotomy with intramuscular tunneling in end-stage achalasia
por: Mavrogenis, Georgios, et al.
Publicado: (2021)